GPR84 inhibitor ameliorated lung inflammation and modulated NF-κB through MAPK signalling pathway

DOI: https://doi.org/10.21203/rs.3.rs-165574/v2

Abstract

The authors have requested that this preprint be withdrawn due to erroneous posting.

Full Text

The authors have withdrawn this preprint from Research Square.